Abstract
Background
Paraneoplastic syndromes are “remote” complications of cancer characterized clinically by neurological disease. The sera and cerebrospinal fluid (CSF) from patients with paraneoplastic neurological syndromes (PNS) frequently contain autoantibodies to ill-defined neuronal antigens. We report here that neuronal glutamate receptors are targets for autoantibodies found in the serum from some patients with well-characterized PNS.
Materials and Methods
We have analyzed the serum from seven patients with well-characterized PNS for the presence of autoreactive antibodies to non-NMDA glutamate receptor subunits. Autoantibodies were assessed using Western blot, immunohistochemistry, and immunocytochemistry. Whole-cell electrophysiological recordings were used to examine the effect of antibodies on glutamate receptors expressed by cortical neurons in culture.
Results
Six of seven patients’ serum contained autoantibodies to the non-NMDA glutamate receptor (GluR) subunits GluR1, GluR4, and/or GluR5/6. No patient had autoantibodies to GluR2, and only one patient exhibited weak immunoreactivity to GluR3. Electrophysiological analysis demonstrated that the serum from four of the six GluR-antibody-positive patients enhanced glutamate-elicited currents on cultured cortical neurons but had no effect on receptor function alone. Enhancement of glutamate-elicited currents was also produced by affinity-purified antibody to GluR5.
Conclusions
The occurrence of autoantibodies to specific neuronal neurotransmitter subunits in the sera of patients with PNS and the ability of these autoantibodies to modulate glutaminergic receptor function suggest that some paraneoplastic neurological injury could result from glutamate-mediated excitotoxicity.
Similar content being viewed by others
References
Choi DW. (1992) Excitotoxic cell death. J. Neurobiol. 23: 1261–1276.
Cunningham J, Graus F, Anderson N, et al. (1986) Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 36: 1169–1172.
Graus F, Elkon KB, Cordon-Cardo C, Posner JB. (1986) Sensory neuronopathy and small-cell lung cancer: Antineuronal antibody that also reacts with the tumor. Am. J. Med. 45: 45–52.
Greenlee JE, Brashear HR. (1983) Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann. Neurol. 14: 609–613.
Greenlee JE, Brashear HR, Herndon MR. (1988) Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. J. Neuropathol. Exp. Neurol. 47: 561–571.
Greenlee JE, Parks TN, Jaeckle, KA. (1993) Type IIa (‘anti-Hu’) antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology 43: 2049–2054.
Hollmann M, Heinemann S. (1994) Cloned glutamate receptors. Annu. Rev. Biochem. 17: 31–108.
Huntley GW, Rogers SW, Moran T, et al. (1993) Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody which recognizes glutamate receptor subunits GluR5/6/7. J. Neurosci. 13: 2965–2981.
Petralia RS, Wenthold RJ. (1992) Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J. Comp. Neurol. 318: 329–354.
Posner JB, Furneaux, HM. (1990) Paraneoplastic Syndromes. Immunological Mechanisms in Neurologic and Psychiatric Disease. Raven Press, New York.
Rogers SW, Hughes TE, Hollmann M, Gassic G, Deneris E, Heinemann SF. (1991) The characterization and localization of the glutamate receptor subunit, GluR1, in the rat brain. J. Neurosci. 11: 2713–2724.
Rogers SW, Mandelzys A, Deneris E, Cooper E, Heinemann SF. (1994) The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J. Neurosci. 12: 4611–4623.
Rogers SW, Andrews PI, Gahring LC, et al. (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science 265: 648–652.
Skeen GW, Twyman RE, White HS. (1993) The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol. Pharmacol. 44: 443–444.
Tsukamaoto T, Yamamoto H, Iwasaki Y, et al. (1989) Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration. Arch. Neurol. 46: 1225–1229.
Acknowledgments
This research was supported by National Institutes of Health Grants NS30990 and AG04418 to SWR and N531519 to RET, the American Federation for Aging Research and American Cancer Society Institutional Research grant to LCG and a U.S. Department of Veterans Affairs Merit Review grant to JG. The authors thank Jessica Tingey for excellent technical assistance. The authors would also like to express their gratitude to Dr. Richard Smith, Denver, CO, and Dr. H. Robert Brashear, University of Virginia, for providing sera from Patients 1 and 3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gahring, L.C., Twyman, R.E., Greenlee, J.E. et al. Autoantibodies to Neuronal Glutamate Receptors in Patients with Paraneoplastic Neurodegenerative Syndrome Enhance Receptor Activation. Mol Med 1, 245–253 (1995). https://doi.org/10.1007/BF03401549
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401549